말기 간질환 환자에서의 호스피스 완화의료 = Hospice and Palliative Care in End Stage Liver Disease

다국어 초록 (Multilingual Abstract)

End-stage liver disease (ESLD) is a terminal condition of cirrhosis which cannot be treated without liver transplantation. Thus, it is natural for patients to consider hospice/palliative care (HPC). Since the recent legislation of the Act on Decisions on Life-Sustaining Treatment for Patients in Hospice and Palliative Care or at the End of Life (Act No. 14013) in Korea, the practicality of this law has become an issue. The criteria for HPC should be defined with consideration to how the severity of each ESLD complication may vary by individual patients. Generally, patients qualify if they have an intractable condition despite aggressive treatment such as the hepatorenal syndrome, hepatic encephalopathy or variceal hemorrhage. However, the option of liver transplantation should be sufficiently discussed with patients and their families before making a decision on HPC. The evaluation of which ESLD patients should receive HPC should be based on a long-term doctor-patient relationship and sufficient objective data. Therefore, a multidisciplinary approach and mutual consultation among cirrhosis specialists and doctors with other expertise are essential to offer optimal and balanced treatments between liver-specific treatment and HPC. Discussed in this review are adequate criteria for HPC and special considerations for ESLD at the point of HPC.

참고문헌 (Reference)

1 Korean Association for study of the Liver, "White Paper on Liver Diseases in Korea" Jin Publishing & Pringing Co 2013

2 Brown J, "Waiting for a liver transplant" 16 : 119-136, 2006

3 Medici V, "The utility of the model for end-stage liver disease score: a reliable guide for liver transplant candidacy and, for select patients, simultaneous hospice referral" 14 : 1100-1106, 2008

4 Stuart B, "The NHO Medical Guidelines for Non-Cancer Disease and local medical review policy: hospice access for patients with diseases other than cancer" 14 : 139-154, 1999

5 Suk KT, "Revision and update on clinical practice guideline for liver cirrhosis" 18 : 1-21, 2012

6 Lynn J, "Perspectives on care at the close of life. Serving patients who may die soon and their families: the role of hospice and other services" 285 : 925-932, 2001

7 Rush B, "Palliative care access for hospitalized patients with end stage liver disease across the United States" Hepatology In press 2017

8 Garcia-Tsao G, "Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis" 51 : 1445-1449, 2010

9 Schuppan D, "Liver cirrhosis" 371 : 838-851, 2008

10 Kim DJ, "Life-sustaining treatment and palliative care in patients with liver cirrhosis-legal, ethical, and practical issues" 23 : 115-122, 2017

11 Kim SY, "Introduction to hospice palliative medicine" 51 : 505-508, 2008

12 Kim MY, "Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension" 55 : 1004-1009, 2011

13 Christakis NA, "Extent and determinants of error in doctors’ prognoses in terminally ill patients: prospective cohort study" 320 : 469-472, 2000

14 Brickner L, "Barriers to hospice care and referrals: survey of physicians’ knowledge, attitudes, and perceptions in a health maintenance organization" 7 : 411-418, 2004

15 Rossaro L, "A strategy for the simultaneous provision of preoperative palliative care for patients awaiting liver transplantation" 17 : 473-475, 2004

16 Ministry of Health and Welfare, "2012 the 5th National health statistics: National nutrition survey" Division of Health Policy, Ministry of Health and Welfare 2013

17 Statistics Korea, "2012 Annual report on the cause of death statistics" Statistics Korea 2013